The Value of Rivaroxaban Combined with Ticagrelor in Antithrombotic Therapy after PCI in Patients with Nonvalvular Atrial Fibrillation with Acute Coronary Syndrome

Objective. Based on a retrospective cohort study, to investigate the value of rivaroxaban combined with ticagrelor in antithrombotic therapy after PCI in patients with nonvalvular atrial fibrillation with acute coronary syndrome. Methods. A total of 60 patients from January 2019 to May 2021 accepted...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Evidence-based complementary and alternative medicine 2022, Vol.2022, p.4807175-7
Hauptverfasser:	Liu, Zhengwang, Qiu, Xiaotang, Yang, Hua, Wu, Xiaocui, Ye, Wenjing, Zheng, Xinbing
Format:	Artikel
Sprache:	eng
Schlagworte:	Acute coronary syndromes Adenosine diphosphate Angina Angina pectoris Angioplasty Anticoagulants Blood flow Blood platelets C-reactive protein Calcium-binding protein Cardiac arrhythmia Cardiovascular disease Clinical medicine Cohort analysis Coronary vessels Creatine Creatine kinase Drug interactions Embolisms Fibrillation Flow velocity Heart attacks Ischemia Kinases Metabolism Myocardial infarction Patients Pharmacokinetics Platelet aggregation Polymorphism Statistical analysis Thrombosis Troponin Troponin I Veins & arteries
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!